Absence of minimal residual disease (MRD) by reverse transcription polymerase chain reaction (RT-PCR) in CBF beta/MYH11-associated acute myeloid leukemia.

被引：0
|
作者：
Marcucci, G
Caligiuri, MA
Oberkircher, AR
Bloomfield, CD
机构：
[1] OHIO STATE UNIV,DIV HEMATOL ONCOL,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,ARTHUR G JAMES CANC HOSP,DIV HUMAN CANC GENET,COLUMBUS,OH 43210
[3] OHIO STATE UNIV,RES INST,COLUMBUS,OH 43210
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：270 / 270
页数：1
相关论文
共 50 条
  • [21] Development of a Reverse Transcriptase Quantitative Polymerase Chain Reaction (RT-qPCR) Assay for Nucleophosmin (NPM1) Minimal Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia
    Mai, M.
    Viswanatha, D. S.
    He, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 932 - 932
  • [22] Prognostic value of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) using polymerase chain reaction (PCR)
    Katsibardi, K.
    Palathanasiou, C.
    Moschovi, M.
    Karamolegou, K.
    Lambrou, G. I.
    Tzortzatou-Stathopoulou, F.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 387 - 387
  • [23] Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia
    G Marcucci
    MA Caligiuri
    H Döhner
    KJ Archer
    RF Schlenk
    K Döhner
    EA Maghraby
    CD Bloomfield
    Leukemia, 2001, 15 : 1072 - 1080
  • [24] Quantification of CBFβ/MYH11 fusion transcript by Real Time RT-PCR in patients with INV(16) acute myeloid leukemia
    Marcucci, G
    Caligiuri, MA
    Döhner, H
    Archer, KJ
    Schlenk, RF
    Döhner, K
    Maghraby, EA
    Bloomfield, CD
    LEUKEMIA, 2001, 15 (07) : 1072 - 1080
  • [25] Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFb/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions.
    Laczika, K
    Mitterbauer, G
    Greinix, HT
    Lechner, K
    Jaeger, U
    BLOOD, 2000, 96 (11) : 313A - 313A
  • [26] Development of a reverse transcription-polymerase chain reaction (RT-PCR) assay for the detection of Amasya cherry disease
    Kozlakidis, Z.
    Citir, A.
    Acikgoz, S.
    Coutts, R. H. A.
    PLANT PATHOLOGY, 2007, 56 (06) : 1032 - 1035
  • [27] Real-time quantitative polymerase chain reaction (RQ-PCR) monitoring of minimal residual disease (MRD) in core binding factor acute myeloid leukaemia (CBF AML).
    Lane, Steven W.
    Saal, Russell
    Mollee, Peter
    Grigg, Andrew
    Taylor, Kerry
    Seymour, John Francis
    Kennedy, Glen
    Williams, Bronwyn
    Jones, Mark
    Grimmett, Karen
    Griffiths, Vanessa
    Gill, Devinder
    Hourigan, Matthew
    Marlton, Paula
    BLOOD, 2006, 108 (11) : 651A - 651A
  • [28] Detection of minimal residual disease using real-time RT-PCR in MLL/AF9 -: Positive acute myeloid leukemia.
    Scholl, C
    Breitinger, H
    Frohling, S
    Schlenk, RF
    Dohner, H
    Dohner, K
    BLOOD, 2003, 102 (11) : 376A - 376A
  • [29] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
    S Viehmann
    A Teigler-Schlegel
    J Bruch
    C Langebrake
    D Reinhardt
    J Harbott
    Leukemia, 2003, 17 : 1130 - 1136
  • [30] Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
    Viehmann, S
    Teigler-Schlegel, A
    Bruch, J
    Langebrake, C
    Reinhardt, D
    Harbott, J
    LEUKEMIA, 2003, 17 (06) : 1130 - 1136
12345